CONTEXT: Patients with incurable cancer engage in several coping styles to manage the impact of cancer and its treatment. The Brief COPE is a widely used measure intended to capture multiple and distinct types of coping. The Brief COPE has not been validated among patients with incurable cancer. OBJECTIVES: We sought to validate seven subscales of the Brief COPE in a large sample of patients newly diagnosed with incurable lung and noncolorectal gastrointestinal cancers (N = 350). METHODS: Participants completed the Brief COPE and measures assessing quality of life (QOL) (Functional Assessment of Cancer Therapy-General) and psychological distress (Hospital Anxiety and Depression Scale) within eight weeks of diagnosis of incurable cancer. We evaluated the psychometric properties of the Brief COPE using a confirmatory factor analysis and tests of correlation with the QOL and distress scales. RESULTS: The Brief COPE factors were consistent with the original subscales, although the Behavioral Disengagement Scale had low internal consistency. Factors showed anticipated relationships with QOL and distress measures, except emotional support coping, which was correlated with increased depression and anxiety. We also conducted an exploratory high-order factor analysis to determine if subscales' score variances grouped together. The high-order factor analysis resulted in two factors, with active, emotional support, positive reframing, and acceptance loading onto one factor and denial and self-blame loading onto the second. CONCLUSION: The selected subscales of the Brief COPE are appropriate measures of coping among individuals newly diagnosed with incurable lung and gastrointestinal cancers.
RCT Entities:
CONTEXT: Patients with incurable cancer engage in several coping styles to manage the impact of cancer and its treatment. The Brief COPE is a widely used measure intended to capture multiple and distinct types of coping. The Brief COPE has not been validated among patients with incurable cancer. OBJECTIVES: We sought to validate seven subscales of the Brief COPE in a large sample of patients newly diagnosed with incurable lung and noncolorectal gastrointestinal cancers (N = 350). METHODS:Participants completed the Brief COPE and measures assessing quality of life (QOL) (Functional Assessment of Cancer Therapy-General) and psychological distress (Hospital Anxiety and Depression Scale) within eight weeks of diagnosis of incurable cancer. We evaluated the psychometric properties of the Brief COPE using a confirmatory factor analysis and tests of correlation with the QOL and distress scales. RESULTS: The Brief COPE factors were consistent with the original subscales, although the Behavioral Disengagement Scale had low internal consistency. Factors showed anticipated relationships with QOL and distress measures, except emotional support coping, which was correlated with increased depression and anxiety. We also conducted an exploratory high-order factor analysis to determine if subscales' score variances grouped together. The high-order factor analysis resulted in two factors, with active, emotional support, positive reframing, and acceptance loading onto one factor and denial and self-blame loading onto the second. CONCLUSION: The selected subscales of the Brief COPE are appropriate measures of coping among individuals newly diagnosed with incurable lung and gastrointestinal cancers.
Authors: Lauren Clevenger; Andrew Schrepf; Koenraad Degeest; David Bender; Michael Goodheart; Amina Ahmed; Laila Dahmoush; Frank Penedo; Joseph Lucci; Premal H Thaker; Luis Mendez; Anil K Sood; George M Slavich; Susan K Lutgendorf Journal: Cancer Date: 2013-06-24 Impact factor: 6.860
Authors: Areej R El-Jawahri; Lara N Traeger; Kailyn Kuzmuk; Justin R Eusebio; Harry B Vandusen; Jennifer A Shin; Tanya Keenan; Emily R Gallagher; Joseph A Greer; William F Pirl; Vicki A Jackson; Karen K Ballen; Thomas R Spitzer; Timothy A Graubert; Steven L McAfee; Bimalangshu R Dey; Yi-Bin A Chen; Jennifer S Temel Journal: Cancer Date: 2014-12-02 Impact factor: 6.860
Authors: Jie Lin; Janice A Blalock; Meng Chen; Yuanqing Ye; Jian Gu; Lorenzo Cohen; Paul M Cinciripini; Xifeng Wu Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-21 Impact factor: 4.254
Authors: Genevieve N Thompson; Harvey M Chochinov; Keith G Wilson; Christine J McPherson; Srini Chary; Fiona M O'Shea; David R Kuhl; Robin L Fainsinger; Pierre R Gagnon; Karen A Macmillan Journal: J Clin Oncol Date: 2009-10-13 Impact factor: 44.544
Authors: Joseph A Greer; Jamie M Jacobs; Areej El-Jawahri; Ryan D Nipp; Emily R Gallagher; William F Pirl; Elyse R Park; Alona Muzikansky; Juliet C Jacobsen; Vicki A Jackson; Jennifer S Temel Journal: J Clin Oncol Date: 2017-11-15 Impact factor: 44.544
Authors: Isaac S Chua; Finly Zachariah; William Dale; Josephine Feliciano; Laura Hanson; Leslie Blackhall; Tammie Quest; Kimberly Curseen; Carl Grey; Ramona Rhodes; Laura Shoemaker; Maria Silveira; Stacy Fischer; Sean O'Mahony; Kostantinos Leventakos; Chardria Trotter; Isabella Sereno; Mihir Kamdar; Jennifer Temel; Joseph A Greer Journal: J Palliat Med Date: 2019-09 Impact factor: 2.947
Authors: Ryan D Nipp; Joseph A Greer; Areej El-Jawahri; Samantha M Moran; Lara Traeger; Jamie M Jacobs; Juliet C Jacobsen; Emily R Gallagher; Elyse R Park; David P Ryan; Vicki A Jackson; William F Pirl; Jennifer S Temel Journal: J Clin Oncol Date: 2017-06-02 Impact factor: 44.544
Authors: Ashley M Nelson; Hermioni L Amonoo; Alison R Kavanaugh; Jason A Webb; Vicki A Jackson; Julia Rice; Mitchell W Lavoie; Amir T Fathi; Andrew M Brunner; Joseph A Greer; Jennifer S Temel; Areej El-Jawahri; Thomas W LeBlanc Journal: Cancer Date: 2021-08-30 Impact factor: 6.921